Recruiting

Observational Study

Sponsor:

Kenneth S. Campbell

Code:

NCT05521503

Conditions

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by a variety of cardiac diseases and therapeutic interventions.

Conditions

Cardiovascular Diseases

Study ID

NCT05521503

Start date

Dec 21, 2021

Status verified date

Jan, 2026

Completion date

Dec, 2030

Anticipated

Primary completion date

Dec, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All patients undergoing evaluation of a cardiac condition or receiving a right heart catheterization with biopsy clinically indicated who are at least 18 years of age.

Exclusion Criteria:

  • Patients without a cardiovascular or amyloidosis diagnosis, under 18 years of age.

Study Design

Enrollment

400 participants

Anticipated

Interventions and Outcome Measures

Arms

Biological specimens

Biological specimens taken from cardiovascular procedures

Primary outcome measure

  • Discover and quantify the concentration of novel diagnostic and prognostic biomarkers [ Time Frame: 12/21/2021-12/31/2030 ]

Central Contacts and Locations

Central contacts

Locations

University of Kentucky

Recruiting

Lexington, Kentucky, United States, 40536

Contacts

Principal Investigator:

Kenneth S Campbell, PhD

More Information

Sponsor

Kenneth S. Campbell

Last update posted

Feb 3, 2026

Last verified

Jan, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Kenneth S. Campbell on 2026-02-03.